National HIV PrEP CurriculumLogo

Activity 4B. Baseline Lab when Starting Tenofovir-DF-Emtricitabine (TDF-FTC)

PDF Share

Learning Objective Performance Indicators

  • Provide a rationale for obtaining baseline laboratory studies prior to starting HIV PrEP
  • List the 2021 and 2025 CDC recommendations for baseline laboratory tests prior to initiating specific HIV PrEP regimens
  • Summarize CDC recommendations for prescribing oral and injectable HIV PrEP, follow-up monitoring, and strategies for providing adherence support
  • Define and describe same-day HIV PrEP, including protocols and exclusions for initiating same-day HIV PrEP
  • Explore the concept of "time to protection" for oral and injectable HIV PrEP

Share by e-mail

Check
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.

You must be signed in to customize your interaction with these questions.

The Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) and Centers for Disease Control and Prevention (CDC) provided financial support for this (website, PowerPoint, podcast, mini-lecture, etc.). The award provided 100% of total costs and totaled $299,994 from HRSA and $603,203 from CDC. The contents are those of the author. They may not reflect the policies of HRSA, HHS, CDC, or the U.S. Government.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.